Found 11 articles for: "risk"
Antiviral Treatment of Herpes Simplex Virus Decreases the Risk of Alzheimer's Disease and Dementia
March 2026 | Volume 25 | Issue 3 | Original Article | 234 | Copyright © March 2026
Background: Alzheimer's disease (AD) and dementia create major global health and economic burdens. Herpes simplex virus (HSV) infects over 3 billion people, and chronic infection...
Read MoreEvaluating the Risk of Atherosclerotic Cardiovascular Disease in Inflammatory Skin Disease: Insights From a TriNetX Cohort Study
December 2025 | Volume 24 | Issue 12 | Original Article | 1181 | Copyright © December 2025
Objective: Recognizing the risk of atherosclerotic cardiovascular disease (ASCVD) in patients is crucial in clinical practice. Recent studies suggest an association between infla...
Read MoreIsotretinoin Does Not Increase the Risk of Inflammatory Bowel Disease: A TriNetX Retrospective Cohort Analysis
December 2025 | Volume 24 | Issue 12 | Original Article | 1168 | Copyright © December 2025
Background: Background: The increasing use of long-term, low-dose isotretinoin for acne has raised concerns about a potential association with inflammatory bowel disease (IBD), i...
Read MoreElevated Atherosclerotic Cardiovascular Disease Risk in Fibrotic Skin Diseases: Insights From a TriNetX Cohort Study
November 2025 | Volume 24 | Issue 11 | Original Article | 1121 | Copyright © November 2025
Background: Identifying the risk of atherosclerotic cardiovascular disease (ASCVD) is a cornerstone of preventive medical care. Despite its significance, limited research has exp...
Read MoreExploring the Cardiovascular Impacts of Oral Nicotinamide: A Comprehensive Narrative Review
November 2025 | Volume 24 | Issue 11 | Original Article | 1075 | Copyright © November 2025
Background: Nicotinamide (niacinamide) is the water-soluble form of vitamin B3. Nicotinamide plays a crucial physiological role as a catalyst for various molecular reactions in t...
Read MoreConnecting the Plaques: Exploring the Link Between Dupilumab and Cutaneous T-cell Lymphoma
November 2025 | Volume 24 | Issue 11 | Features | 1148 | Copyright © November 2025
Increased Odds of Multiple Primary Cancers in Merkel Cell Carcinoma Patients: A Large-Scale Propensity-Matched Analysis
August 2025 | Volume 24 | Issue 8 | Editorials | e51 | Copyright © August 2025
Streamlining Psoriatic Arthritis Screening and Management Using the IDEOM Clinical Framework: A Quality Improvement Initiative
August 2025 | Volume 24 | Issue 8 | Original Article | 777 | Copyright © August 2025
Background: Psoriatic arthritis (PsA) is undiagnosed in up to 41% of cases, risking irreversible joint damage if untreated. This quality improvement initiative facilitates PsA sc...
Read MoreIs Upadacitinib Cardioprotective in Chronic Inflammatory Diseases? A Review of Major Adverse Cardiovascular Events and Venous Thromboembolism in Atopic Dermatitis
May 2025 | Volume 24 | Issue 5 | Original Article | 530 | Copyright © May 2025
Background: Atopic dermatitis (AD) is a chronic inflammatory skin condition associated with risk of cardiovascular disease (CVD), potentially mediated by persistent systemic infl...
Read MoreManagement of Acute Hematomas and Methods to Mitigate Risk
March 2025 | Volume 24 | Issue 3 | Original Article | 289 | Copyright © March 2025
One of the most common complications in dermatologic surgery is postoperative bleeding which can result in hematoma formation and suboptimal healing outcomes. Identifying preoperative, intraopera...
Read MoreCo-occurring Melanoma in an Active Area of Vitiligo in Skin of Color
February 2025 | Volume 24 | Issue 2 | Case Reports | 205 | Copyright © February 2025
The association between vitiligo and melanoma is complex. While the incidence of vitiligo in patients with melanoma is higher, the risk for the reverse, ie, the development of melanoma in a patie...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
